Thomas C. Burdett

818 total citations
11 papers, 583 citations indexed

About

Thomas C. Burdett is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Thomas C. Burdett has authored 11 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Nephrology. Recurrent topics in Thomas C. Burdett's work include Adenosine and Purinergic Signaling (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Nerve injury and regeneration (3 papers). Thomas C. Burdett is often cited by papers focused on Adenosine and Purinergic Signaling (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Nerve injury and regeneration (3 papers). Thomas C. Burdett collaborates with scholars based in United States and Sweden. Thomas C. Burdett's co-authors include Michael A. Schwarzschild, Cody A. Desjardins, Yuehang Xu, Sara Cipriani, Marc Freeman, Lukas J. Neukomm, Xiqun Chen, Robert Logan, Kui Xu and Nikolaus R. McFarland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and PLoS ONE.

In The Last Decade

Thomas C. Burdett

11 papers receiving 580 citations

Peers

Thomas C. Burdett
Edwin Vázquez‐Rosa United States
Davor Ivankovic United Kingdom
Yinyi Sun China
Prasad Konkalmatt United States
Thomas C. Burdett
Citations per year, relative to Thomas C. Burdett Thomas C. Burdett (= 1×) peers Chuen‐Lin Huang

Countries citing papers authored by Thomas C. Burdett

Since Specialization
Citations

This map shows the geographic impact of Thomas C. Burdett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Burdett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Burdett more than expected).

Fields of papers citing papers by Thomas C. Burdett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Burdett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Burdett. The network helps show where Thomas C. Burdett may publish in the future.

Co-authorship network of co-authors of Thomas C. Burdett

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Burdett. A scholar is included among the top collaborators of Thomas C. Burdett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Burdett. Thomas C. Burdett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bratkowski, Matthew, Thomas C. Burdett, Jean Danao, et al.. (2022). Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease. Neuron. 110(22). 3711–3726.e16. 40 indexed citations
2.
Bratkowski, Matthew, Tian Xie, Desiree A. Thayer, et al.. (2020). Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1. Cell Reports. 32(5). 107999–107999. 86 indexed citations
3.
Farley, Jonathan E., Thomas C. Burdett, Romina Barría, et al.. (2018). Transcription factor Pebbled/RREB1 regulates injury-induced axon degeneration. Proceedings of the National Academy of Sciences. 115(6). 1358–1363. 33 indexed citations
4.
Neukomm, Lukas J., Thomas C. Burdett, Andrew M. Seeds, et al.. (2017). Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly. Neuron. 95(1). 78–91.e5. 77 indexed citations
5.
Neukomm, Lukas J., Thomas C. Burdett, Michael Gonzalez, Stephan Züchner, & Marc Freeman. (2014). Rapid in vivo forward genetic approach for identifying axon death genes in Drosophila. Proceedings of the National Academy of Sciences. 111(27). 9965–9970. 54 indexed citations
6.
McFarland, Nikolaus R., Thomas C. Burdett, Cody A. Desjardins, Matthew P. Frosch, & Michael A. Schwarzschild. (2013). Postmortem Brain Levels of Urate and Precursors in Parkinson's Disease and Related Disorders. Neurodegenerative Diseases. 12(4). 189–198. 52 indexed citations
7.
Cipriani, Sara, Cody A. Desjardins, Thomas C. Burdett, et al.. (2012). Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease. PLoS ONE. 7(5). e37331–e37331. 52 indexed citations
8.
Cipriani, Sara, Cody A. Desjardins, Thomas C. Burdett, et al.. (2012). Protection of dopaminergic cells by urate requires its accumulation in astrocytes. Journal of Neurochemistry. 123(1). 172–181. 33 indexed citations
9.
Chen, Xiqun, Thomas C. Burdett, Cody A. Desjardins, et al.. (2012). Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration. Proceedings of the National Academy of Sciences. 110(1). 300–305. 98 indexed citations
10.
Burdett, Thomas C., Cody A. Desjardins, Robert Logan, et al.. (2012). Efficient determination of purine metabolites in brain tissue and serum by high‐performance liquid chromatography with electrochemical and UV detection. Biomedical Chromatography. 27(1). 122–129. 20 indexed citations
11.
Healy, Brian C., et al.. (2010). Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease. Brain Research. 1367. 310–318. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026